Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Multiple Sclerosis
Interventions
PROCEDURE

MSC Treatment

Intravenous administration of up to 2x10\^6 autologous MSCs per kg

Trial Locations (2)

CB2 0PY

University of Cambridge Dept of Clinical Neurosciences, Cambridge

WC1N 3BG

University College London Institute of Neurology, London

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Cambridge University Hospitals NHS Foundation Trust

OTHER

collaborator

Medical Research Council

OTHER_GOV

lead

University of Cambridge

OTHER